Development and characterization of controlled release mucoadhesive tablets of captopril

Ars Pharmaceutica

Volumn 52, Issue 2, 2011, Pages 31-37

  Dalvadi, H P ^a   Patel, J K ^b   Rajput, G C ^b   Muruganantham, V ^c   Jayakar, B ^c  

^a CKPithawalla Institute Of Pharmaceutical Science and Research   (India)

^b NOOTAN PHARMACY COLLEGE   (India)

^c VINAYAKA MISSION S RESEARCH FOUNDATION DEEMED TO BE UNIVERSITY   (India)

Author keywords

Captopril; Gastro retentive tablet; Mucoadhesive tablets; Swelling index

Indexed keywords

CAPTOPRIL; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; XANTHAN;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFUSION; DRUG DESIGN; DRUG RELEASE; EVALUATION; IN VITRO STUDY; MATRIX TABLET; MEAN RESIDENCE TIME; MUCOADHESION; TABLET FORMULATION; TABLET PROPERTY; VISCOSITY;

EID: 79957517835     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlledrelease drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996; 22 (6): 531-539. (Pubitemid 26197851)
2. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel. 2000; 63(3): 235-259.
3. Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavi PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm. 2006; 316(1): 86-92. (Pubitemid 43765689)
4. Park, K. Robinson, J.R. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm. 1984; 19(2): 107-127.
5. Machida Y, Masuda H, Fujiyama N, Ito S, Iwata M, Nagai T. Preparation and phase II clinical examination of topical dosage form for treatment of carcinoma colli containing bleomycin with hydroxypropyl cellulose. Chem Pharm Bull. 1979; 27(1): 93-100. (Pubitemid 9114502)
6. Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano MY. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agents Chemother. 1998; 42(10): 2492-2494. (Pubitemid 28462884)
7. Singh B, Chakkal SK, Ahuja N. Formulation and Optimization of Controlled Release Mucoadhesive Tablets of Atenolol Using Response Surface Methodology. AAPS Pharm Sci Tech. 2006; 7 (1): E19-E28.
8. Mathiowitz E, Chickering DEI, Lehr CM. Bioadhesive Drug Delivery Systems. Marcel Dekker, New York. 1999.
9. Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug-delivery. Adv Drug Deliver Rev. 1995; 16(1): 45-50.
10. Ziyaur Rahman M, Ali RK Khar. Design and evaluation of bilayer floating tablets of captopril. Acta Pharm. 2006; 56:49-57.
11. Anaizi NH, Swenson C. Instability of captopril solution. Am J Hosp Pharm. 1993; 50: 486-488.
12. Seta Y, Kawahara Y, Nishimura K, Okada R. Design and preparation of captopril sustained release dosage forms and their biopharmaceutical properties. Int J Pharm. 1988; 41(3): 245-254. (Pubitemid 18034878)
13. Nafee NA, Ismail FA, Nabila AB, Mortada LM. Mucoadhesive Delivery Systems. II. Formulation and In-Vitro/In-Vivo Evaluation of Buccal Mucoadhesive Tablets Containing Water-Soluble Drugs. Drug Dev Ind Pharm. 2004; 30 (9): 995-1004.
14. Chowdary KPR. Suresh B, Sangeeta B, Reddy GK. Design and Evaluation of Diltiazem Mucoadhesive Tablets for Oral Controlled Release. Saudi Pharm J. 2003; 11(4): 201-205. (Pubitemid 38094724)
15. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd Ed. Varghese publishing house: Mumbai, 1987; 293-345.
16. Baumgartner S, Kristel J, Vreer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm. 2000; 195(1-2): 125-135. (Pubitemid 30089497)
17. Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm. 2002; 28(4): 431-442. (Pubitemid 34552236)
18. Duchene D, Touchard F, Peppas N. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm. 1988; 14(2): 283-318.
19. Lueßen HL, Lehr CM, Rentel CO, Noach AB, de Boer JAG, Verhoef JC, Junginger HE. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Rel. 1994; 29: 329-338. (Pubitemid 24156379)
20. Wang, J.,Tabata,Y., Bi, D., Morimoto, K., Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. J. Control. Rel. 2001; 73: 223-231.
21. Xu G, Sunada H. Influence of formulation change on drug release kinetics from HPMC matrix tablet. Chem Pharm Bull. 1995; 43(3): 538-550.
22. Bamba M, Puisieusx F. Release mechanism in gel forming sustained release preparations. Int J Pharm. 1979;2(5-6):307-315 (Pubitemid 9161631)